Gilead Sciences Inc (GILD)
92.57
+1.48
(+1.62%)
USD |
NASDAQ |
Dec 20, 16:00
92.57
0.00 (0.00%)
After-Hours: 20:00
Gilead Sciences Total Liabilities (Quarterly): 36.14B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 126.92B |
| Eli Lilly and Co | 61.29B |
| Merck & Co Inc | 72.97B |
| AbbVie Inc | 137.35B |
| Amgen Inc | 83.36B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 54.52B |
| Shareholders Equity (Quarterly) | 18.47B |
| Debt to Equity Ratio | 1.258 |
| Current Ratio | 1.261 |
| Net Debt Paydown Yield | 0.38% |